St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer.
The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.)
Galera (NASDAQ: GRTX) is developing proprietary therapies that have theā¦
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: John George Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Health Management | Pancreas | Pancreatic Cancer | Study